Rapid drying of retinal fluid with faricimab injections may help identify patients with neovascular age-related macular degeneration who can safely extend time between injections.

Patients with treatment-naive neovascular age-related macular degeneration have positive outcomes with faricimab at 1 year, ...

BARCELONA, Spain — Early findings from a real-world study of the dual-action antibody faricimab have shown sustained improvement in visual acuity and key biomarkers of retinal anatomy, with no new ...

Please provide your email address to receive an email when new articles are posted on . “Trained expert readers validated the accuracy of the segmentation, each macular scan from baseline to week 56 ...

A recent study published in JAMA Network Open reveals that higher levels of exposure to outdoor artificial light at night can increase the risk of incident exudative age-related macular degeneration.

Geographic atrophy due to age-related macular degeneration (AMD) is the leading cause of irreversible blindness and affects more than 5 million persons worldwide. No therapies to restore vision in ...